Dementia in people with intellectual disabilities Mental and Behavioural Disorders
Conditions
Interventions
Current intervention as of 17/03/2022:
Fifty individuals with intellectual disabilities and dementia will be randomised to either the intervention group or control group (treatment as usual). Randomis
Sponsors
North East London NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current participant inclusion criteria as of 14/03/2023: 1. Premorbid mild or moderate intellectual disabilities (based on clinical notes) 2. Aged 18 and over 3. Clinical diagnosis of mild or moderate dementia based on service records 4. Ability to provide informed consent or (if the participant lacks capacity) availability of a personal consultee who has agreed to participate in the study 5. Ability to communicate in English Previous participant inclusion criteria: 1. Mild or moderate Learning disabilities 2. ICD-10 diagnosis of mild or moderate dementia
Exclusion criteria
Exclusion criteria: Current participant exclusion criteria as of 14/03/2023: 1. Significant visual or hearing impairment that may interfere with participation 2. Significant physical illness or disability, affecting the ability to attend groups 3. Significant behavioural problems that could affect participation (e.g. aggressive behaviour) Previous participant exclusion criteria: 1. Severe learning disabilities 2. Severe dementia 3. Visual or hearing impairment that prevents participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 14/03/2023: 1. Cognitive functioning measured using the Severe Impairment Battery (SIB) and Dementia in Learning Disabilities Questionnaire (DLD) at 2 weeks prior to the intervention and then followed up 2 weeks following the intervention 2. Adaptive functioning measured using The Dementia in Learning Disabilities Questionnaire (DLD) at 2 weeks prior to the intervention and 2 weeks following the intervention 3. Quality of life measured using the Quality of life in Alzheimer’s Dementia (QoL-AD) proxy questionnaire and the EQ-5L-5D quality of health questionnaires at 2 weeks prior to the intervention and two weeks following the intervention 4. Feasibility of collecting the cost-effectiveness measures measured using Clinical Service Receipt Inventory (CSRI) at 2 weeks prior to the intervention and two weeks following the intervention 5. A process evaluation will include qualitative interviews with participants, staff and carers to identify aspects of the intervention and study methods including adherence at the end of the intervention 6. Overall attendance amongst the CST group participants by recording the attendance of each participant in each group session. This will be given to the researchers following the intervention 7. Feasibility of recruitment measured using recruitment, eligibility rate, consent rate and retention data in study records at the end of the intervention 8. To assess the suitability of study outcome measures and determine the primary outcome measure for a future larger RCT measured using the data outcomes of the tools used at pre- and post-intervention 9. Acceptability and feasibility of CST measured using overall attendance data for the CST groups in study records, and fidelity measured using recordings of the groups at the end of the intervention Previous primary outcome measures: 1. Cognitive functioning measured using the Severe Impairment Battery (SIB) and Dementia in Learning Disabilities Questionnai | — |
Secondary
| Measure | Time frame |
|---|---|
| The fidelity of delivery of the groups measured using: 1. Number of group CST sessions completed by each participant measured using the group attendance register at the end of the data collection. 2. Level of engagement in the sessions measured using CST participation forms developed alongside the CST manual recorded during the sessions collected after the interventions by the researchers. | — |
Countries
England, United Kingdom
Contacts
Public ContactAimee Spector
Outcome results
None listed